← The Wire
PHARNasdaq
Pharming Group N.V.
Pharmaceutical Preparations · P7 · CIK 1828316
Pharming Group develops and commercializes innovative therapies for rare and ultra-rare diseases
$904M
Market cap
$13.40
Last close
+0.5%
1D
+5.4%
5D
9K
Volume
Price · last 39 sessions-18.2%
May 4L $12.00 · H $16.40Jun 29
117
Total filings
Jun 4, 2026
Last filing
12/31
Fiscal year end
6-K6-KJun 4, 20266-K6-KMay 28, 20266-K6-KMay 22, 20266-K6-KMay 7, 20266-K6-KMay 7, 20266-K6-KApr 16, 20266-K6-KApr 2, 202620-F20-FApr 2, 20266-K6-KMar 27, 20266-K6-KMar 24, 20266-K6-KMar 12, 20266-K6-KFeb 3, 20266-K6-KFeb 2, 20266-K6-KJan 8, 20266-K6-KNov 6, 20256-K6-KOct 22, 20256-K6-KOct 6, 20256-K6-KOct 1, 20256-K6-KSep 10, 20256-K6-KSep 2, 20256-K6-KJul 31, 20256-K6-KJun 24, 20256-K6-KJun 11, 20256-K6-KMay 8, 20256-K6-KApr 30, 20256-K6-KApr 25, 20256-K6-KApr 23, 20256-K6-KApr 3, 202520-F20-FApr 3, 20256-K6-KMar 20, 20256-K6-KMar 13, 20256-K6-KMar 4, 20256-K6-KFeb 20, 20256-K6-KFeb 7, 20256-K6-KJan 21, 20256-K6-KJan 21, 20256-K6-KDec 16, 20246-K6-KDec 11, 2024SC 13GMS INITIALNov 8, 20246-K6-KOct 24, 20246-K6-KOct 10, 20246-K6-KSep 26, 20246-K6-KAug 1, 20246-K6-KMay 30, 20246-K6-KMay 21, 20246-K6-KMay 15, 20246-K6-KMay 8, 20246-K6-KApr 25, 20246-K6-KApr 24, 20246-K6-KApr 8, 20246-K6-KApr 4, 202420-F20-FApr 4, 20246-K6-KMar 14, 2024SC 13GPHARMING GROUP N.V.Feb 14, 20246-K6-KJan 8, 20246-K6-KDec 15, 20236-K6-KNov 13, 20236-K6-KOct 26, 20236-K6-KSep 25, 20236-K6-KAug 14, 20236-K6-KAug 9, 20236-K6-KAug 3, 20236-K6-KJul 18, 20236-K6-KJun 1, 20236-K6-KMay 19, 20236-K6-KMay 11, 20236-K6-KApr 11, 202320-F20-FApr 5, 20236-K6-KApr 5, 20236-K6-KMar 27, 20236-K6-KMar 16, 20236-K6-KMar 13, 20236-K6-KMar 13, 20236-K6-KFeb 21, 20236-K6-KFeb 17, 20236-K6-KOct 27, 20226-K6-KAug 4, 20226-K6-KAug 2, 20226-K6-KAug 1, 20226-K6-KJun 2, 2022
Similar companies
Comparable business profile · signals at a glance